STRUCTURAL-GEOMETRIC INDICATORS OF THE LEFT VENTRICLE IN THE EVALUATION OF ELECTRICAL REMODELATION OF THE HEART OF THE HEAD OF CHRONIC SYSTEMIC INFLAMMATION IN THE INFLAMMATION
DOI:
https://doi.org/10.21802/2304-7437-2021-2022-16-17(61-62)-39-48Keywords:
stable coronary artery disease, diabetes mellitus, markers of chronic systemic inflammation.Abstract
Stable coronary artery disease in combination with type 2 diabetes mellitus remains one of the leading causes of disability and mortality. Therefore, the study of prognostic factors in the combination of these diseases remains relevant. The question of the influence of the inflammatory component on the development of atherosclerosis in patients with CCS in combination with type 2 diabetes mellitus is studied in this article. The influence of the severity of chronic systemic inflammation on the features of myocardial remodeling in such a combined pathology remains unclear.
The aim of the study was to evaluate the features of LV myocardial remodeling on the background of chronic systemic inflammation in patients with stable coronary artery disease with concomitant type 2 diabetes mellitus.
120 patients were examined, including 90 patients with SCAD and type 2 diabetes mellitus (group I) and 30 patients with SCAD (group II). Patients in both groups had SCAD: angina class II-III by CCS classification. It was found that in patients with SCAD and type 2 diabetes mellitus and without it, type 1 diastolic heart dysfunction prevailed (relaxation disorders). Prognostically unfavorable type of remodeling, concentric LV hypertrophy, predominated in patients with SCAD associated with type 2 diabetes.
The study showed that the increase in the integrated indicators of chronic systemic inflammation in patients with SCAD with concomitant type 2 diabetes mellitus associated with diastolic left ventricular dysfunction, hyperlipidemia, and this should be considered when choosing tactics of patient management.
Conclusion: In our opinion, local disruption of lipid transport in the tissue is the basis of atherosclerotic lesions of the vascular wall, which develops independently of inflammation in it, but is significantly potentiated by the mediators of inflammation.
Reconstruction of structural and functional parameters of the heart and disorders of intracardiac hemodynamics are characteristic of patients with SCAD without and in combination with type 2 diabetes mellitus, and in the latter case is more profound. These processes are initiated and deepened against the background of chronic systemic inflammation, which may be marked with elevated levels of ST2, hs-SRP, TMAO, TLR2, TLR4 and hematological indices.
References
Коваленко В. М., Борткевич О. П. Коморбідність: визначення, можливі напрямки діагностики та лікування // Український ревматологічний журнал. 2019. Т. 3. № 77. С. 33–44.
Кошля В. І., Піскун А. В. Когортне проспективне дослідження стану серця та судин у хворих на ішемічну хворобу серця у поєднанні з цукровим діабетом 2 типу // Science Rise: Medical Science. 2019. Т. 31. № 4. С. 8–14.
Паньків В. І. Порушення вуглеводного обміну в клінічній практиці // Міжнародний ендокринологічний журнал. 2017. Т.13,№ 1. С. 39–44.
Уніфікований клінічний протокол первинної вторинної (спеціалізованої) та третинної (високоспеціалізованої) медичної допомоги (УКПМД) «Стабільна ішемічна хвороба серця». Наказ Міністерства охорони здоров’я України від 23.12.2021 № 2857 // 2021.
Уніфікований клінічний протокол первинної вторинної (спеціалізованої) та третинної (високоспеціалізованої) медичної допомоги (УКПМД) «Цукровий діабет ІІ типу». Наказ МОЗ України №1118 від 21.12.2012 року // 2012.
Хіміон Л. В. и др. Фактори ризику ішемічної хвороби серця та розвиток гострого коронарного синдрому в осіб з нормальними показника-ми ліпідного обміну // Семейная медицина. 2016. № 2. С. 95–98.
Cosentino F. и др. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force for diabetes, prediabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) // European Heart Journal. 2020. Т. 41. № 2. С. 255–323.
Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart dis-ease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies // BMJ. 2006. Т. 332. № 7533. С. 73–78.
Kvetny J. и др. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular dis-ease in males below 50 years // Clinical Endocrinology. 2004. Т. 61. № 2. С. 232–238.
Lang R. M. и др. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging // European Heart Journal – Cardiovascular Imaging. 2015. Т. 16. № 3. С. 233–271.
Li M. и др. Prognostic value of ST2 for MACEs and all-cause mortality in patients with coronary artery disease during a long-term follow up // 2020.
Liu Y. и др. Systemic immune-inflammation index predicts the severity of coronary stenosis in patients with coronary heart disease // Coronary Artery Disease. 2021. Т. 32. № 8. С. 715–720.
Marwick T. H. и др. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardi-ovascular Imaging (EACVI) and the American Society of Echocardiography (ASE) // European Heart Journal - Cardiovascular Imaging. 2015. Т. 16. № 6. С. 577–605.
Mykhailovska N. S., Miniailenko L. Y. The state of vascular endothelium, clinical and metabolic features of patients with coronary heart disease combined with nonalcoholic fatty liver disease // Патологія. 2017. № 14,№ 1. С. 62–67.
Nagueh S. F. и др. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American society of echocardiography and the European association of cardiovascular imaging // European Heart Journal Cardiovascular Imaging. 2016. Т. 17. № 12. С. 1321–1360.
Pellicori P. и др. Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure // European Journal of Heart Failure. 2019. Т. 21. № 7. С. 904–916.
Rubattu S., Forte M., Raffa S. Circulating Leukocytes and Oxidative Stress in Cardiovascular Diseases: A State of the Art // Oxidative Medicine and Cellular Longevity. 2019. Т. 2019. С. 1–9.
Salvador B. и др. Modulation of endothelial function by Toll like receptors // Pharmacological Research. 2016. Т. 108. С. 46–56.
Senthong V. и др. Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand // Scientific Reports. 2021. Т. 11. № 1. С. 14963.
Williams B. и др. 2018 ESC/ESH Guidelines for the management of arterial hypertension // European Heart Journal. 2018. Т. 39. № 33. С. 3021–3104.
